Synovial Sarcoma, X Breakpoint 2B (SSX2B) (AA 21-70) Antikörper
-
- Target Alle Synovial Sarcoma, X Breakpoint 2B (SSX2B) Antikörper anzeigen
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
-
Bindungsspezifität
- AA 21-70
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human SSX2B
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa21-70 of human SSX2B (Q16385-2). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product SSX2B Primärantikörper
-
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) antibody
SSX2B Reaktivität: Human WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (N-Term) antibodySSX2B Reaktivität: Human, Hund, Maus, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS, 2 % sucrose.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short term: 4°C
Long term: -20°C.
-
- Target
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
- Andere Bezeichnung
- SSX2B (SSX2B Produkte)
- Hintergrund
-
Name/Gene ID: SSX2B
Synonyms: SSX2B
-
